Mizolastine

咪唑斯汀

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameMizolastine
Drug Alias Namemizolastina咪唑司汀咪唑斯丁mizolastinemizolastinum +[13] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionHistamine H1 receptor antagonists
TargetsHistamine H1 receptor
Therapy Area/IndicationsHypersensitivityUrticariaConjunctivitis +[4] 
Global Approved IndicationsHypersensitivityUrticariaConjunctivitis +[4] 
Approved Indications in ChinaHypersensitivityUrticariaConjunctivitis +[4] 
Original Approved Country/TerritoryMainland China
Original Approved Date2001/03/09
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesN/A
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesXian Janssen Pharmaceutical Ltd
Active IndicationsHypersensitivityUrticariaConjunctivitis +[4] 
Inactive IndicationsN/A

Other Information

ATC CodeR06AX25
Related LinksWikipediaKEGG